Excilite µ

Description

Excilite µ

Progressive Action to Combat Vitiligo and Psoriasis: No Drugs, Painless, Rapid

The Excilite μ monochromatic excimer light, MEL@308 nm, offers the ideal solution for restoring wellbeing in just a few sessions

Excilite μ provides a great mix of advantages both to the patients and to the physicians:

• A long-lasting, clinically proven technology: DEKA invented the first MEL@308 nm system in the world in 2001
• A safe wavelength that minimizes side effects such as erythema and burns using the high selectivity of 308 nm wavelength
• Keeps healthy skin untouched by selecting special filters that change the dimension of the irradiation area
• Fast treatment times can be performed thanks to the 30 cm² handpiece
• Low maintenance costs thanks to the long-lasting MEL@308 nm lamp source: over 5000-treatment lifetime

The Advantages of Excilite μ over Traditional Phototherapy

Excilite μ combines the advantages of traditional phototherapy with UV lamps (such as NB UVB or PUVA) and phototherapy with excimer lasers. Excilite μ protects the healthy perilesional skin thanks to its special filters, it minimizes side effects such as erythema and burns, it doesn’t require the use of drugs, the re-pigmentation process is faster and effective in all areas.

Excilite μ in Comparison with Excimer Lasers

Like excimer lasers, Excilite-μ has a monochromatic emission with the same wavelength of 308 nm and high intensity (50 mW/cm²). However, compared to lasers, Excilite-μ offers significant advantages: Treated areas are larger (30 cm² spot size), treatments are faster and the maintenance costs are significantly reduced.